Welcome to CDC Stacks | Pearl Kendrick, Grace Eldering, and the Pertussis Vaccine - 18263 | Emerging Infectious Diseases
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Pearl Kendrick, Grace Eldering, and the Pertussis Vaccine
  • Published Date:
    Aug 2010
  • Source:
    Emerg Infect Dis. 16(8):1273-1278.
Filetype[PDF - 163.84 KB]


Details:
  • Personal Authors:
    Shapiro-Shapin, Carolyn G.
  • Keywords:
  • Description:
    In light of the reemergence of pertussis (whooping cough), the pioneering research of Pearl Kendrick and Grace Eldering is worth revisiting. In the 1930s, working in the Michigan Department of Health laboratory in Grand Rapids, Michigan, USA, they began researching a pertussis vaccine. Their research offers an instructive case study of the creative public health research performed in state health department laboratories during the interwar years. State department of health laboratory directors actively promoted research by supporting advanced education; making facilities and funding available for individual projects; and, when possible, procuring new facilities. Using Michigan Department of Health resources and local and federal funding, Kendrick and Eldering developed standardized diagnostic tools; modified and improved extant vaccines; conducted the first successful, large-scale, controlled clinical trial of pertussis vaccine; and participated in international efforts to standardize and disseminate the vaccine. Their model may again offer a promising avenue for groundbreaking research.

  • Document Type:
    Journal Article
  • Collection(s):
    Emerging Infectious Diseases
No Related Documents.
You May Also Like:
  1. Pertussis vaccination: acellular pertussis vaccine for reinforcing and booster use--supplementary ACIP statement. Recommendations of the Immunization Practices Advisory Committee (ACIP).
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 1992; 41(RR-1):1-10.
    Description:
    This supplementary statement provides information on and recommendations for the use of diphtheria and tetanus toxoids and acellular pertussis vaccine (DTaP). One such vaccine was recently licensed, ACEL-IMMUNE.* This vaccine is licensed for use only...
    Status:
    superseded
    File Type:
    Filetype[HTML]
  2. Pertussis vaccination: acellular pertussis vaccine for the fourth and fifth doses of the DTP series update to supplementary ACIP statement. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 1992; 41(RR-15):1-5.
    Description:
    General recommendations on pertussis prevention were issued August 8, 1991, in the ACIP statement on diphtheria, tetanus, and pertussis (1). A supplementary statement on the use of diphtheria and tetanus toxoids and acellular pertussis vaccine (DTaP)...
    Status:
    superseded
    File Type:
    Filetype[HTML]
  3. Preventing tetanus, diphtheria, and pertussis among adults; use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine : recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Personal Author:
    Kretsinger, Katrina.; Broder, Karen R.; Cortese, Margaret M.; Joyce, Patricia; Ortega-Sanchez, Ismael; Lee, Grace M.; Tiwari, Tejpratap; Cohn, Amanda C.; Slade, Barbara A.; Iskander, John K.; Mijalski, Christina M.; Brown, Kristin H.; Murphy, Trudy V.;
    Corporate Author:
    National Immunization Program (Centers for Disease Control and Prevention; Centers for Disease Control and Prevention (U.S.), Immunization Safety Office.; United States, Advisory Committee on Immunization Practices;
    Published:
    December 15, 2006
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 2006; 55(RR-17):1-37.
    Series:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. v. 55, no. RR-17
    Description:
    On June 10, 2005, a tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) formulated for use in adults and adolescents was licensed in the United States for persons aged 11--64 years (ADACEL®, manufactured by sanofi pasteu...
    Status:
    current
    File Type:
    Filetype[PDF - 418.34 KB]
  4. Diphtheria, tetanus, and pertussis: recommendations for vaccine use and other preventive measures. Recommendations of the Immunization Practices Advisory committee (ACIP).
    Corporate Author:
    Centers for Disease Control (U.S.). Immunization Practices Advisory Committee.
    Published:
    August 08, 1991
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 1991; 40(RR-10):1-28.
    Description:
    This revision of the Immunization Practices Advisory Committee (ACIP) statement on diphtheria, tetanus, and pertussis updates the statement issued in 1985, and incorporates the 1987 supplementary statement, which addressed two issues: a) the risks an...
    Status:
    superseded
    File Type:
    Filetype[HTML]
  5. Health Facility Characteristics and Their Relationship to Coverage of PMTCT of HIV Services across Four African Countries: The PEARL Study
    Personal Author:
    Ekouevi, Didier K.; Stringer, Elizabeth; Coetzee, David; Tih, Pius; Creek, Tracy; Stinson, Kathryn; Westfall, Andrew O.; Welty, Thomas; Chintu, Namwinga; Chi, Benjamin H.; Wilfert, Cathy; Shaffer, Nathan; Stringer, Jeff; Dabis, Francois;
    Published:
    Jan 20 2012
    Source:
    PLoS One. 2012; 7(1).
    Description:
    Background : Health facility characteristics associated with effective prevention of mother-to-child transmission of HIV (PMTCT) coverage in sub-Saharan are poorly understood. : Methodology/Principal Findings : We conducted surveys in health faciliti...
    File Type:
    Filetype[PDF - 166.78 KB]